Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes
Top Cited Papers
- 1 September 2012
- journal article
- Published by Elsevier BV in Journal of Clinical Epidemiology
- Vol. 65 (9), 989-995
- https://doi.org/10.1016/j.jclinepi.2012.02.018
Abstract
No abstract availableKeywords
Funding Information
- Australian National Health and Medical Research Council (301916)
This publication has 39 references indexed in Scilit:
- Aging, Drugs, and Drug MetabolismThe Journals of Gerontology, Series A: Biological Sciences and Medical Sciences, 2011
- Association of polypharmacy with nutritional status, functional ability and cognitive capacity over a three‐year period in an elderly populationPharmacoepidemiology and Drug Safety, 2011
- Frailty and use of health and community services by community-dwelling older men: the Concord Health and Ageing in Men ProjectAge and Ageing, 2010
- Drugs With Anticholinergic Properties, Cognitive Decline, and Dementia in an Elderly General PopulationArchives of Internal Medicine, 2009
- Pain, frailty and comorbidity on older men: The CHAMP studyPain, 2008
- Youden Index and Optimal Cut‐Point Estimated from Observations Affected by a Lower Limit of DetectionBiometrical Journal, 2008
- A 12-Item Short-Form Health SurveyMedical Care, 1996
- A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validationPsychological Medicine, 1994
- Clinical diagnosis of Alzheimer's diseaseNeurology, 1984
- Development and validation of a geriatric depression screening scale: A preliminary reportJournal of Psychiatric Research, 1983